- Home
- BCG vs BRNS Comparison
BCG vs BRNS Comparison
Compare BCG & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCG
- BRNS
- Stock Information
- Founded
- BCG 2016
- BRNS 2016
- Country
- BCG United States
- BRNS United Kingdom
- Employees
- BCG N/A
- BRNS N/A
- Industry
- BCG
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- BCG
- BRNS Health Care
- Exchange
- BCG Nasdaq
- BRNS Nasdaq
- Market Cap
- BCG 45.6M
- BRNS 41.0M
- IPO Year
- BCG N/A
- BRNS 2021
- Fundamental
- Price
- BCG $2.14
- BRNS $1.11
- Analyst Decision
- BCG
- BRNS Strong Buy
- Analyst Count
- BCG 0
- BRNS 2
- Target Price
- BCG N/A
- BRNS $4.00
- AVG Volume (30 Days)
- BCG 66.9K
- BRNS 63.4K
- Earning Date
- BCG 11-14-2024
- BRNS 11-06-2024
- Dividend Yield
- BCG N/A
- BRNS N/A
- EPS Growth
- BCG N/A
- BRNS N/A
- EPS
- BCG N/A
- BRNS N/A
- Revenue
- BCG $161,721,000.00
- BRNS $14,969,000.00
- Revenue This Year
- BCG N/A
- BRNS $1,805.74
- Revenue Next Year
- BCG N/A
- BRNS N/A
- P/E Ratio
- BCG N/A
- BRNS N/A
- Revenue Growth
- BCG N/A
- BRNS 106.21
- 52 Week Low
- BCG $1.85
- BRNS $0.80
- 52 Week High
- BCG $16.61
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- BCG N/A
- BRNS 54.91
- Support Level
- BCG N/A
- BRNS $0.98
- Resistance Level
- BCG N/A
- BRNS $1.25
- Average True Range (ATR)
- BCG 0.00
- BRNS 0.14
- MACD
- BCG 0.00
- BRNS 0.03
- Stochastic Oscillator
- BCG 0.00
- BRNS 68.82
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.